Utilizing Tumor and Plasma Liquid Biopsy in Treatment Decision Making for an Estrogen Receptor-Positive Advanced Breast Cancer Patient
Bing Xu(First Affiliated Hospital of Xiamen University), Brian Leyland‐Jones(Avera Health), Rachel Elsey(Cancer Institute (WIA)), Pradip De(University of South Dakota), Jessica Klein(Cancer Institute (WIA)), Casey Williams(Creighton University), Amy Krie(Amgen (United States))
Cited by 15
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
|Nature Medicine|2019|726
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL
|Cancer Immunology Research|2019|181
Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2
|Cell Death and Disease|2017|142
RET rearrangements are actionable alterations in breast cancer
|Nature Communications|2018|127